Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
111,699,977
-
Share change
-
-19,762,862
-
Total reported value
-
$167,540,454
-
Put/Call ratio
-
2.6%
-
Price per share
-
$1.50
-
Number of holders
-
112
-
Value change
-
-$26,479,106
-
Number of buys
-
46
-
Number of sells
-
70
Institutional Holders of RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) as of Q4 2022
As of 31 Dec 2022,
RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,699,977 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, D. E. Shaw & Co., Inc., MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.